anti-drug antibodies in about 51% (diabetes) to 64.5% (obesity) of users with no effect on clearance, weight, or HbA1c: FDA Mounjaro NDA 215866 label and Summary Review
Their involvement in cancer cell growth and differentiation, and in the development of resistance to anticancer agents, has made them attractive drug targets
doi:10.1186/s13287-019-1248-3 333
It is a record that can help research teams compare identity, purity, test method, lot number, date, and supplier documentation
This is an extensive consultation process that includes WADAs List Expert Advisory Group gathering information including the latest scientific and medical research, trends, and intelligence gathered from law enforcement and pharmaceutical companies